週刊現代eyamashita11012024年7月15日読了時間: 1分研究員 谷本哲也【コメント】Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals 2024.07.12https://gendai.media/articles/-/133268?page=1&imp=0
Comments